)
UroGen Pharma (URGN) investor relations material
UroGen Pharma AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
The meeting was called to order by the CEO, who welcomed shareholders and outlined the agenda, including a Q&A session at the end.
The CEO introduced the management team, legal counsel, and the Inspector of Elections, and confirmed the meeting was held virtually.
Financial performance review
Highlighted the successful launch of ZUSDURI, the first FDA-approved treatment for a specific type of bladder cancer, with strong early adoption.
Noted continued growth of JELMYTO and advancement of next-generation pipeline products, including UGN-103, UGN-104, and UGN-501.
Board and executive committee updates
Seven directors were nominated for election to serve until the 2027 annual meeting.
- ZUSDURI's rapid adoption and robust pipeline position the company for long-term uro-oncology growth.URGN
Goldman Sachs 47th Annual Global Healthcare Conference 202610 Jun 2026 - ZUSDURI drives robust growth and adoption, with pipeline assets advancing toward key milestones.URGN
7th Annual Oncology Innovation Summit: Insights for ASCO & EHA1 Jun 2026 - ZUSDURI's durable efficacy, expanding adoption, and robust IP strategy drive long-term growth.URGN
H.C. Wainwright 4th Annual BioConnect Investor Conference19 May 2026 - Strong Q1 growth, durable efficacy, and pipeline expansion highlighted at upcoming conferences.URGN
Bank of America Global Healthcare Conference 202613 May 2026 - Q1 revenue jumped 152% year-over-year, driven by ZUSDURI's rapid adoption and new debt refinancing.URGN
Q1 202612 May 2026 - Six key proposals, board independence, performance-based pay, and ESG oversight headline the meeting.URGN
Proxy filing1 May 2026 - 2026 meeting covers board elections, governance, compensation, equity, and ESG priorities.URGN
Proxy filing17 Apr 2026 - ZUSDURI adoption accelerates post J-code, driving growth and highlighting a $1.2B opportunity.URGN
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - ZUSDURI™ and JELMYTO® set new standards in urothelial cancer care with strong growth and innovation.URGN
Corporate presentation3 Mar 2026
Next UroGen Pharma earnings date
Next UroGen Pharma earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage